The Lancet: Hetlioz, Taken Daily at Fixed Time, Promotes Master Body Clock Entrainment
Pivotal trial results of Vanda Pharmaceuticals’ Hetlioz (tasimelteon) related to patient entrainment are published in the August issue of The Lancet. The trial results are from the SET (Safety and Efficacy of Tasimelteon)...